Leukemia can cause abnormal white blood cells to accumulate in the bone marrow and bloodstream. Some patients have very high white blood cell counts, while others may have normal or low counts.
A high white blood cell count does not automatically indicate leukemia. Infections, inflammation, medications, and other conditions can also increase the count.
Likewise, a normal total count does not necessarily exclude leukemia. The distribution and appearance of cells, the presence of abnormal immature cells, and the rest of the blood-count results can be important.
In certain forms of leukemia, the abnormal cells are immature and do not perform the normal functions expected of healthy white blood cells. Consequently, a person may have many white blood cells yet still be vulnerable to infection.
This is one reason why symptoms must be considered alongside laboratory findings rather than judged by a single number.
The Role of Platelets
Platelets help blood clot when a blood vessel is damaged. They gather at the site of an injury and participate in the process that stops bleeding.
When platelet levels fall, bruising may become more frequent and bleeding may take longer to stop. Some people develop petechiae, nosebleeds, bleeding gums, or heavier-than-usual menstrual bleeding.
Low platelet counts can occur for many reasons, including certain infections, medication effects, immune conditions, and bone marrow disorders.
In leukemia, reduced platelet production can be one consequence of abnormal cells disrupting normal bone marrow activity.
Unexplained bruising becomes more concerning when it occurs with additional abnormalities, such as anemia, recurrent infections, or an abnormal white blood cell count. Even then, further investigation is required to determine the actual cause.
Acute and Chronic Leukemia
Leukemia is not one disease. It includes several types that differ in the cells affected, the genetic changes involved, and the speed at which the disease develops.
Four major categories are commonly discussed:
-
Acute lymphoblastic leukemia (ALL): A cancer involving immature lymphoid cells. It is particularly common in children but also occurs in adolescents and adults.
-
Acute myeloid leukemia (AML): A cancer involving myeloid blood-forming cells. It can develop rapidly and often requires prompt specialist evaluation and treatment.
-
Chronic lymphocytic leukemia (CLL): A disease involving certain mature-appearing lymphocytes. It is primarily diagnosed in older adults and may initially produce few symptoms.
-
Chronic myeloid leukemia (CML): A myeloid-cell cancer frequently associated with a genetic change called the Philadelphia chromosome, which creates the BCR::ABL1 fusion gene.
These categories are not interchangeable. Their biology, diagnostic criteria, treatment options, and typical clinical courses differ.
A 23-year-old could develop certain forms of leukemia, but age alone does not establish which type is involved or what the outcome might be. Some forms are more common in younger people, while others occur predominantly later in life.
Why Leukemia Can Affect More Than the Blood
Although leukemia begins in blood-forming cells, abnormal cells can accumulate in other tissues.
Some patients develop enlarged lymph nodes, discomfort beneath the ribs because of an enlarged spleen, or a feeling of fullness after eating small amounts. Others experience bone or joint pain.
Certain forms can involve the central nervous system or other organs, but the likelihood and pattern depend on the specific disease.
These symptoms are not unique to leukemia. Enlarged lymph nodes commonly occur during infections, and abdominal discomfort can have many causes. Their significance depends on the clinical context.
How Doctors Establish the Diagnosis
The diagnostic process usually begins with a medical history, physical examination, and complete blood count. A blood smear may allow a specialist to examine the shape and appearance of individual blood cells.
If the findings raise concern for leukemia, a bone marrow examination may be necessary. During this procedure, clinicians collect a sample of bone marrow, commonly from the pelvic bone, to examine the cells directly.
Additional laboratory investigations may include flow cytometry, chromosome analysis, and molecular testing. These tests help identify the abnormal cell population and the genetic changes that may influence treatment.
The results allow specialists to classify the leukemia more precisely and select an appropriate treatment strategy.
This process matters because two people with the same broad diagnosis may have different biological features that influence their treatment and prognosis.
Why the Science Matters
Understanding blood-cell production helps explain why symptoms such as bruising, fatigue, and infection can occur together. It also explains why those symptoms cannot independently establish a diagnosis.
Leukemia requires laboratory confirmation and specialist evaluation. No photograph, social media caption, or isolated physical sign can replace that process.
For someone who is worried about their health, the most productive next step is not to guess which type of leukemia they might have. It is to obtain a professional assessment and allow the evidence to guide the investigation.
That approach reduces unnecessary fear while ensuring that serious conditions are not overlooked.
Chapter 3: From the First Blood Test to a Diagnosis — The Medical Journey
Receiving an unexpected medical result can be overwhelming. A person may arrive at a clinic expecting reassurance about fatigue or bruising and discover that further investigations are necessary.
When leukemia is suspected, the period between the first abnormal result and a confirmed diagnosis can involve uncertainty, repeated testing, and conversations with several healthcare professionals.
Understanding the process can help patients and their families know what to expect, although the exact sequence varies according to symptoms, laboratory findings, and the type of leukemia being considered.
The Initial Consultation
The first stage is often a conversation about symptoms and medical history.
A clinician may ask when the symptoms began, whether they are worsening, and whether the patient has experienced fever, unexplained weight loss, night sweats, unusual bleeding, or recurrent infections.
Other questions may cover medications, previous illnesses, family medical history, recent infections, and potential sources of blood loss.
A physical examination may include checking the skin for bruising or petechiae, assessing lymph nodes, and examining the abdomen for signs of an enlarged liver or spleen.
These findings help determine which investigations are appropriate. However, a physical examination alone cannot confirm or exclude leukemia.
The Complete Blood Count
A complete blood count, often called a CBC, measures several components of the blood.
It typically includes red blood cell measurements, hemoglobin, platelet count, and the total number of white blood cells. A differential count provides additional information about the types of white blood cells present.
Abnormalities may raise concern when several cell lines are affected or when immature cells appear in the bloodstream.
For example, a patient might have anemia and a low platelet count. Another might have an unusually high white blood cell count with abnormal cells visible on a blood smear.
These patterns can indicate a problem involving the bone marrow, but they are not sufficient by themselves to identify every possible cause.
A clinician may order repeat testing or refer the patient urgently to a hematologist, a specialist in blood disorders.
The Blood Smear
A blood smear involves spreading a small blood sample across a glass slide and examining the cells under a microscope.
This allows laboratory professionals to assess cell appearance and identify abnormalities that automated counting equipment may not fully characterize.
In some cases, immature cells called blasts are visible. Their presence can be an important clue that further evaluation is needed.
However, the interpretation depends on the clinical situation, and not every abnormal blood smear indicates leukemia.
The purpose of this examination is to add detail to the blood-count results and help guide the next stage of investigation.
Bone Marrow Examination
If leukemia is suspected, doctors may recommend a bone marrow aspiration and biopsy.
Bone marrow aspiration collects a liquid sample containing marrow cells. A biopsy collects a small core of tissue. The procedures are commonly performed using the pelvic bone, with local anesthesia and additional pain management when appropriate.
Patients may feel pressure or brief discomfort during parts of the procedure. The healthcare team explains how to prepare, what sensations to expect, and how to care for the site afterward.
The samples are examined to determine which cells are present, how they are developing, and whether abnormal populations are interfering with normal blood formation.
Not every patient follows precisely the same diagnostic pathway, but bone marrow assessment is an important component of evaluating many suspected leukemias.
Flow Cytometry and Genetic Testing
Modern leukemia diagnosis goes beyond identifying abnormal cells under a microscope.
Flow cytometry uses markers on cells to help determine their type and developmental stage. This can distinguish different forms of leukemia that may look similar under routine examination.
Chromosome analysis and molecular testing can identify genetic changes associated with particular diseases. These findings may help establish the diagnosis, estimate risk, and select targeted treatments.
For example, identifying the BCR::ABL1 fusion gene is central to diagnosing and managing CML and certain cases of ALL.
Other genetic findings may influence decisions about chemotherapy, targeted drugs, immunotherapy, or stem cell transplantation.
Because leukemia is biologically diverse, accurate classification is essential. Treatment should be based on the specific disease rather than a generalized assumption that every leukemia requires the same regimen.
What Happens After Confirmation?
Once the diagnosis is established, the specialist explains the type of leukemia, the relevant test results, and the proposed treatment plan.
The discussion may include additional tests to assess organ function, infection risk, genetic features, and other factors that influence treatment decisions.
Some patients need treatment urgently, especially when the disease is acute or is causing significant complications. Others, particularly certain patients with chronic leukemia, may be suitable for carefully monitored observation before treatment begins.
This difference can be surprising. Many people assume that every cancer must be treated immediately, but the appropriate timing depends on the disease and the individual's condition.
For acute leukemia, delays can be dangerous, and prompt specialist management is generally essential. For selected chronic conditions, immediate treatment may offer no advantage over monitoring until clear treatment criteria are met.
The Emotional Impact of Waiting
The diagnostic process can be emotionally demanding even before a final answer is available.
A patient may worry about their family, employment, finances, or the possibility of long-term treatment. Friends and relatives may struggle to find the right words, particularly when they do not know whether the suspected diagnosis will be confirmed.
It can help to write down questions before appointments, bring a trusted person when permitted, and ask the clinician to explain unfamiliar medical terms.
Patients can also request clarification about which findings are confirmed, which remain uncertain, and what the next test is intended to establish.
A suspected diagnosis is not the same as a confirmed diagnosis. Understanding that distinction can prevent unnecessary assumptions while the medical team completes its assessment.
The Value of Early Evaluation
Seeking medical attention for persistent symptoms does not mean expecting the worst. It means allowing clinicians to investigate problems before they become more difficult to manage.
If leukemia is present, timely diagnosis can help the patient reach the appropriate specialist and begin treatment when needed. If the symptoms have another cause, testing may help identify that cause and guide treatment.
The medical process may involve uncertainty, but it also provides a structured way to move from symptoms toward answers.
For a young adult facing the possibility of cancer, that structure can be an important source of clarity. Rather than relying on frightening online stories, patients can focus on the information obtained from their own examination and test results.
The goal is not to eliminate every fear immediately. It is to replace uncertainty with reliable information, one step at a time.
Chapter 4: Treatment, Recovery, and the Reality of Living With Leukemia at 23
A leukemia diagnosis can change a young adult's priorities almost overnight. Plans for education, work, relationships, and independence may suddenly need to be reconsidered. Medical appointments become more frequent, unfamiliar terminology enters everyday conversations, and decisions about treatment can feel overwhelming.
Yet leukemia is not a single disease with one universal treatment. The appropriate approach depends on the specific type, its genetic characteristics, the patient's overall health, and the way the disease responds to therapy.
Treatment has advanced considerably over recent decades, and many people with leukemia now have effective options that were unavailable to earlier generations. Outcomes still vary widely, however, and no individual prognosis can be determined from age or symptoms alone.
Chemotherapy and Acute Leukemia
Chemotherapy uses medicines that destroy cancer cells or prevent them from multiplying. It remains an important treatment for several forms of acute leukemia, although the exact regimen differs according to the disease.
Treatment may involve an initial phase designed to achieve remission, followed by additional therapy intended to reduce the risk of relapse. Some patients require prolonged treatment, while others may be considered for stem cell transplantation or newer targeted and immune-based approaches.
Chemotherapy can also affect healthy cells that divide rapidly. This can lead to side effects such as nausea, hair loss, mouth sores, fatigue, and reduced production of normal blood cells.
When blood counts fall, patients may become more vulnerable to infections, anemia, or bleeding. Medical teams monitor these risks through laboratory testing, supportive medications, transfusions when needed, and other interventions.
Not every patient experiences the same side effects. Some tolerate treatment better than expected, while others need adjustments or additional support.
For people with acute leukemia, the treatment plan may change as doctors assess the response to therapy and the results of follow-up tests.
Targeted Therapy and Immunotherapy
Some forms of leukemia have specific biological features that can be targeted with medication.
Targeted therapies act on particular molecules or pathways involved in cancer-cell growth. In CML, for example, drugs that inhibit the abnormal BCR::ABL1 protein have transformed treatment for many patients.
Other leukemia subtypes may be treated with targeted medicines directed at particular genetic changes or cellular mechanisms.